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1. Introduction 
Atopic dermatitis (AD) is a form of allergic skin inflammation characterized by late 
eczematous skin lesions [1]. These skin lesions occur through non-Immunoglobulin E (non-
IgE)-mediated immune responses, and therefore, AD can be regarded as a non-IgE-mediated 
allergic inflammatory skin disease [2]. Many causes, including inhalant allergens, food 
allergens, and other factors, have been implicated in AD [1]. In addition to information about 
the causes, knowledge of the immunologic nature of AD is extremely important in order to 
understand AD. Without an understanding of the immunologic nature of AD, the cause of 
food allergy in patients with AD may be wrongly identified. Because of this confusion in 
establishing the cause of a food allergy in AD, the role of food allergy in AD remains poorly 
understood [2]. However, with the recent advance in the diagnosis and treatment of food 
allergy, it is necessary inevitably to distinguish between IgE- and non-IgE-mediated food 
allergies that co-exist with AD in order to better understand and control AD [2]. 
It is well-known that food allergy is an important cause of atopic dermatitis [3]. Although food 
allergies can be either IgE- or non-IgE-mediated, due to a lack of diagnostic modalities such 
as laboratory tests to diagnose non-IgE-mediated food allergy [4], it is difficult to clarify the 
nature of the food allergy, leading to confusion about role of food allergy in AD. Tests that 
determine IgE levels cannot predict the likelihood of an eczematous reaction because 
eczematous reactions are the result of non-IgE-mediated food allergies [2]. 
Until recently, discrimination of IgE-mediated and non-IgE-mediated food allergies was not 
considered necessary for diagnosis or treatment. Therapeutic modalities, including tolerance 
induction for food allergy (TIFA), have been developed for patients with food allergy [5,6]. 
However, the principles for diagnosing and treating IgE-mediated or non-IgE-mediated 
food allergies are quite different [7]. Presently, a differential diagnosis is absolutely 
necessary for relevant, proper, and successful treatment of IgE-mediated and non-IgE-
mediated food allergies, independently. Clinical approaches to treat food allergy in AD 
patients, including laboratory tests and diagnosis, should consider the conceptual 
differences between IgE-mediated and non-IgE-mediated food allergies. 
In the past, avoidance has been suggested as the main principle for treating food allergies 
[8]. More recently, however, the clinical and laboratory characteristics of IgE-mediated and 
non-IgE-mediated food allergy in atopic dermatitis have been well-characterized, and the 
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relevant treatment techniques, including tolerance induction for food allergy (TIFA), have 
been markedly advanced and well-established [7]. In this chapter, updates on the diagnosis 
and relevant treatments for food allergy in AD are described 
2. Atopic dermatitis 
2.1 Definition 
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease [1] that is 
characterized by non-IgE-mediated allergic skin inflammation, in which allergen-specific 
Th2 cells play a major role in the pathogenesis of the inflammation [2]. The appearance of 
atopic dermatitis is characterized by late eczematous reactions, which result from an 
allergen-specific Th2 immune response. 
2.2 Immunopathogenesis of AD with food allergy 
The immunologic phases of food allergy in AD include a sensitization phase and an effector 
phase (Fig. 1) [2]. During the sensitization phase, the tolerance of a subject to a specific 
allergen is determined. Response to that allergen, either allergic or tolerant, occurs in the 
effector phase. 
 
 
Fig. 1. Scheme of immunopathogenesis of food allergy in atopic dermatitis. When allergen is 
challenged, the immune system check the memory. In the neosensitization, immunologic 
memory of allergy is induced in the Th2 polarized status, or tolerized in normal status. In 
the immunologic process, IgE-mediated allergy or non-IgE-mediated allergy is formed 
when food allergen is to be memorized to react as allergic reactions. If food allergen is re-
challenged, atopic dermatitis is appeared by non-IgE-mediated food allergy or IgE-mediated 
allergy including urticaria to anaphylactic shock occured. If allergen is memorized being 
tolerant, there is no reaction even by any further challenge by allergen. IgE-mediated food 
allergy and non-IgE-mediated allergy is apparently different in the immunopathogenesis as 
well as clinical manifestations.  
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Humans are continually challenged by foreign particles, including pathogens and foods. 
Protection from these foreign substances is mediated by effective immune responses 
(effectors). Protection from immune responses directed against food occurs by an immune 
tolerance response (tolerance). Allergy is one type of effector immune response that is the 
consequence of allergic sensitization. Allergic sensitization occurs from a Th1/Th2 
imbalance [9]. There are 2 classes of allergic effector mechanisms: IgE-mediated and non-
IgE-mediated allergic reactions. An IgE-mediated allergic response occurs if allergen-
specific IgE is activated after exposure to the specific allergen. IgE-mediated immune 
reactions include urticaria, asthma, and rhinitis. 
IgE has been positioned at the center of focus in allergy and allergic disease research. 
However, a major characteristic of AD is its non-IgE-mediated response.  
3. Clinical characteristics of food allergy in AD 
3.1 Clinical features of AD 
The clinical phenotype of AD varies with age and course of the disease [10]. The eczematous 
lesions may present as acute (oozing, crusted, or eroded vesicles or papules on 
erythematous plaques), subacute (thick and excoriated plaques), or chronic (lichenified, 
slightly pigmented, or excoriated plaques) forms. Furthermore, xerosis and a lowered 
threshold for itching are usual hallmarks of AD. Pruritus attacks can occur throughout the 
day and worsen at the night, causing insomnia, exhaustion, and a substantial impairment in 
quality of life. To date, the symptoms and signs of AD have been listed horizontally. 
However, the primary clinical manifestations of AD include eczematous skin lesions and 
itching caused by allergen-specific Th2 immune responses. Some clinical manifestations of 
AD, including papule, plaque, and xerosis, are descriptions of skin manifestations; some 
manifestations, including excoriation, are related to the primary AD symptoms and signs; 
and some manifestations, including viral infection and impetigo, insomnia, and exhaustion, 
are secondary to the primary symptoms and signs. 
3.2 Clinical features of food allergy in AD 
The clinical manifestations of IgE-mediated food allergy (IFA) are uniform in AD and in the 
absence of AD; they include dermatologic manifestations, such as immediate urticaria and 
rashes, as well as other cardiovascular and respiratory symptoms and signs [2].  
The clinical manifestations of non-IgE-mediated food allergy (NFA) are not uniform. 
Although IFA has been described as a central immunopathogenesis of atopic dermatitis, the 
symptoms and signs of IFA do not correspond to those of atopic dermatitis. Rather, the 
symptoms and signs of NFA are those of atopic dermatitis itself. 
Food allergies have clinical manifestations on the skin as well as gastrointestinal and 
respiratory systems. Cutaneous reactions have been categorised as non-eczematous versus 
eczematous and early versus late [11]. Non-eczematous reactions tend to occur immediately 
after exposure to the food, usually immediately or within less than 1 hour. The typical 
reactions include pruritus, urticaria, angioedema, and diffuse morbilliform erythema. These 
reactions do not cause immediate exacerbations of AD, and they are commonly associated 
with gastrointestinal or respiratory symptoms. Acute urticaria and angioedema are among 
the most common symptoms, and acute contact urticaria or allergy can also occur. One-half 
of the reactions after the ingestion of milk are not mediated by specific IgE antibodies to 
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milk protein and are lost by the age of 3 years. Eczematous reactions has been regarded as 
occurring less frequently. They usually manifest as a late event, generally defined as 
occurring 2 to 6 hours or more after exposure to the food. As has already been shown, 
eczematous reactions can develop infrequently as an early event or in combination with 
non-eczematous reactions.  
The symptoms and signs of NFA are not uniform; they vary according to subjects and foods 
[2]. In addition, in one subject, various symptoms and signs often develop according to the 
food ingested. The onset time of symptoms and signs of NFA ranges from 2 hours to several 
days, up to even a week, after intake [12]. Because it is very difficult to predict the onset time 
of NFA symptoms, physicians should observe patients long enough to cover the maximum 
onset time following challenge or intake during daily life. The clinical manifestations of 
NFA show patterns of their own with respect to onset time, the severity of clinical 
manifestations, and type of allergy.  
It should be kept in mind that AD patients, as well as other food allergy patients, may be 
allergic to multiple food allergens [13]. These patients may also have multiple types of food 
allergy, such as IFA and NFA, together. However, when this is the case, patients will not 
necessarily have both IFA and NFA simultaneously to the same food. The diagnosis, 
management, and treatment of food allergy in AD should be approached keeping in mind 
that subjects may have food allergies to multiple foods and that they may exhibit multiple 
types of food allergies including both IFA and NFA. 
3.3 Types of foods that cause atopic dermatitis 
Based on OFC outcomes, the most common food allergens in the United States, 
accounting for the vast majority of food allergies in patients, are known as cow's milk, 
hen's eggs, peanuts, soy, wheat, tree nuts, and shellfish [14]. Although some children 
prove to be truly allergic to meats, fruits, vegetables, or other grains, the vast majority 
have negative OFCs for these foods.  
As confirmed in several studies, cow’s milk, hen’s eggs, wheat, soy, and peanuts are 
responsible for approximately 75% of food-associated AD [15,16] in IFA, whereas for NFA, 
meats as well as cow’s milk, hen’s eggs, soy and wheat were the major causes of AD [13].  
In Western country, Hen’s eggs and cow’s milk are significantly more likely to result in IFA 
and are associated with elevated food-specific IgE [11]. Soy and wheat are more likely to 
cause late eczematous flares, but reactions to cow’s milk were also observed. Although some 
of these reactions are observed in the context of elevated food-specific IgE, some also occur 
in the absence of food-specific IgE. 
The same food can provoke IFA and NFA. In recent studies, foods were mapped according 
to the kinds of food allergy (IFA or NFA) and severity [7]. Such mapping is necessary for the 
proper management of food allergy in atopic dermatitis. 
3.4 Mixed-type allergy: The simultaneous presence of two different types of food 
allergy, IFA and NFA, in AD 
Because IFA and NFA are present together in atopic dermatitis, the characteristics of AD 
that result from each of these two types of food allergy should be clarified [7]. It is generally 
understood that IFA, rather than NFA, plays a central role in the immunopathogenesis of 
AD until recently [12]. Immediate reactions in IFA often lead to increased scratching and, 
eventually, secondary exacerbation of eczematous lesions [11], whereas direct exacerbation 
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of AD with development of new eczematous outbreaks tends to occur as a late reaction 
and infrequently as an early reaction. However, in its clinical and immunopathogenic 
aspects, NFA is similar to AD. With the advent of successful treatments for food allergy, 
IFA is less so. In this chapter, AD are described, especially in the viewpoint of non-IgE-
mediated food allergy. 
3.5 Multiple food allergies in AD 
Multiple sensitisation to foods in IFA 
Multiple sensitisation with foods has not been generally considered a possible cause of AD; 
this is another point that can easily confuse clinicians and patients. The prevalence of data 
describing multiple food allergies in published studies provides an estimate of multiple 
food allergy prevalence [7, 13]. In a study of food allergies in a highly atopic group of 
children, all of whom had atopic dermatitis and 50% of whom had concurrent asthma or 
allergic rhinitis, 57% reacted to two or three foods during double-blind, placebo-controlled 
food challenges [17]. Most children in this subset had positive skin prick tests (SPTs) to 
several foods, although only approximately one third of positive tests correlated with 
positive food challenge [13]. However, few children reacted to more than three foods [18]. 
Five foods (eggs, peanuts, milk, wheat, and soy) accounted for approximately 60% of the 
positive clinical responses in this study [19].  
More than 500 random serum samples were evaluated for specific IgE against six common 
food allergens (milk, eggs, wheat, soy, peanuts, and cod) [17]. They addressed that having 
evidence of IgE-mediated sensitisation to a food does not necessarily imply a true food 
allergy. This study found that 27% of children were sensitised to more than one of the six 
foods. The main limitation of this retrospective study was that information regarding 
clinical reactivity to foods was not available; therefore, it is not known how many of these 
patients were truly allergic to more than one food.  
A recent study examining the prevalence of multiple food allergies found that most 
(>70%) food-allergic children were allergic to or were avoiding multiple foods [17]. On 
average, each child was avoiding three or four foods or food groups. These children were 
generally very atopic, with 56% showing atopic dermatitis, 47% having allergic rhinitis, 
and 38% having asthma. Thus, highly atopic children may be at greater risk for allergies 
to multiple foods. 
Sensitisation to multiple foods in AD 
Although food allergies are not the only cause of AD, in many cases AD is caused by 
multiple food allergies. Over 50% of AD patients also exhibited NFA to a mean of 2.8 
food items [18]. Moreover, IFA co-exists simultaneously with AD and NFA [7]. 
Interestingly, in most cases, patients with isolated IFA did not have AD. From these 
results, it seems clear that NFA is the major type of food allergy in AD, although IFA is 
the aggravating cause of AD. 
4. Diagnosis of food allergy in AD 
The diagnosis of food allergy should be made following the discrimination of IgE- and 
non-IgE-mediated allergies. Diagnostic protocols for IFA have been proposed by various 
researchers, institutes and academic societies; however, the concept of dosage 
www.intechopen.com
 Atopic Dermatitis – Disease Etiology and Clinical Management 
 
234 
quantitation, along with the measurement of clinical severity changes on the basis of 
discrimination of IgE- and non-IgE-mediated food allergy, has clearly become the most 
important point in successful immunotherapy [7]. Because both the diagnostic and the 
therapeutic protocols for IgE- and non-IgE-mediated food allergies differ greatly, the 
major points in these protocols should be revised. 
The two most important points regarding diagnosis of food allergy in atopic dermatitis 
are as follows: 1) distinction should be made between IFA and NFA and 2) the treatment 
dosage must be calibrated and the clinical severity assessed for the purposes of therapy 
and follow-up [7]. 
4.1 Allergy history  
A detailed clinical history is the key first step in the diagnosis of potential food allergy, 
followed by skin testing and immunoassay testing when indicated by the history [14]. 
Ultimately, however, in cases of non-anaphylactic reactions and especially non-IgE-
mediated food allergies, OFCs may be required for an accurate diagnosis. 
Parents often consider their child’s AD as an “allergic” manifestation of a presumed food 
allergy [11]. Although the influence of the media and popular culture may play a role, 
parents also receive differing opinions from primary care providers and dermatologists [11]. 
Greater than 90% of parents and 60% of primary care providers may suspect food allergy as 
the cause of AD, resulting in referrals to allergists and extensive testing.  
Food allergies should be suspected from the patient’s history of experiences of allergy 
provocation, especially in case of IgE-mediated food allergy [7]. However, apart from major 
immediate anaphylactic reactions, patient history has proven to be an unreliable way to 
diagnose food allergies [3]. A poor correlation between food allergy and medical history, 
with only 25%-48% sensitivity overall and a 72%-97% specificity for IFA, has been reported. 
Moreover, in NFA it is more difficult for patients and parents to recognise the relationship 
between the ingested food and allergy provocation because of the difficult clinical 
characteristics as well as delayed reactions of this condition, and a history of NFA is 
inconsistent with the final diagnosis of NFA [18]. The additional possibility of exercise-
induced food allergy should be considered and excluded by history. 
4.2 Laboratory approaches to food allergy in AD 
Blood eosinophil numbers 
Increases in blood eosinophil counts due to NFA provocation by OFC have been 
demonstrated and blood eosinophilia is useful simply as a clue in the diagnosis of allergy 
[20]. The level of blood eosinophils has clinical significance as a predictor of the efficacy of 
IFN- therapy in atopic dermatitis [21].  
Total IgE 
Although not all patients with AD have elevated IgE, as many as 40% to 80% [11] have been 
found to have high food-specific IgE levels. Total IgE does not seem to be associated with 
current allergic disease activity.  
ECP 
Eosinophil cationic protein (ECP) is produced by activated eosinophils [22]. Food 
additives were shown to elevate blood ECP in atopic dermatitis [23]. Interestingly, ECP is 
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elevated without the elevation of blood eosinophil numbers in AD patients and even in 
normal subjects in recent studies conducted [24]. In this report, food additives were 
shown to provoke xerosis (dry skin) and resultant pruritus consistent with AD. Among 
patients suspected to have AD, over 30% showed pseudoallergies to food additives [25]. 
The signs and symptoms caused by food additives can interfere with the interpretation of 
OFC and with the therapeutic process. ECP is specifically elevated in patients who ingest 
artificial chemical food additives [24] and elevated ECP has been used as a marker of 
pseudoallergic reactions due to food additives, particularly when blood eosinophil 
numbers are normal.  
Skin prick test and specific IgEs in IFA 
IFA is approached initially by tests for allergen-specific IgE. The skin prick test (SPT) has a 
high negative predictive value (approximately 95%) and is most informative when it is 
negative; the positive predictive value ranges between 30% and 50% [3]. Therefore, SPT is 
useful for excluding IFA, but a positive result may only be suggestive of IFA. Laboratory 
testing for food-specific IgEs also has a high negative predictive value, estimated to be 75%, 
but its positive predictive value is low, ranging from 20% to 60%. Recently, the diagnostic 
levels of food-specific IgEs have been determined. The presence of specific IgEs at or above 
these levels offers a positive predictive value of approximately 95% for IFA. Although skin 
prick tests and serum IgE measurements can confirm sensitisation, neither of these tests can 
on its own prove clinical allergy to a specific food with reliability or consistency. Moreover, 
IgE-based laboratory tests will only predict IFA; IgE-based tests are not useful for the 
diagnosis of NFA in AD [18]. 
In spite of the extremely high specific IgE and strong SPT usually associated with HDM, 
HDM rarely induces anaphylactic reactions following exposure. In contrast, food-induced 
IgE-mediated allergies, including systemic urticaria and anaphylactic allergic reactions, 
can occur when a patient has high specific IgE levels or strong skin reactivity for a food 
allergen. 
Interpretation of polysensitisation from the results by the SPT or allergen-specific IgE 
Polysensitisation to multiple allergens as the result of allergen-specific IgE and skin prick 
tests, especially to multiple food allergens, may be embarrassing to the physician. 
Sensitisation of the skin caused by the skin prick test and the presence of specific IgE do not 
indicate the presence of allergy [2]. 
In cases of skin sensitisation, patients often show similar reactions (itching, rash, or 
urticaria) to contact with allergen in the skin prick test. Therefore, patients should avoid 
allergens which are positive by the skin prick test. Sensitisation to specific allergens by 
allergen-specific IgE does not always provoke allergy. Based on the level of allergen-
specific IgE, IgE-mediated allergy can be predicted, especially for food allergens. 
Therefore, physicians should just consider IgE-mediated food allergy if patients have high 
food-specific IgE. 
Allergy patch test 
The immunopathogenesis of eczematous allergic reactions to food that occurs in non-IgE-
mediated food allergy is similar to that of allergic contact dermatitis in that it is T lymphocyte-
mediated and associated with food-specific T lymphocytes [3]. For these reasons, atopic patch 
testing (APT) has been used to investigate food-induced eczema.  
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Laboratory follow-up 
Blood eosinophils provide information on current disease activity of the non-IgE-mediated 
type [20]. For the evaluation of disease progress and continuing disease activity and for the 
effective management of non-IgE-mediated allergy including NFA, blood eosinophil levels 
are tested repeatedly on a regular schedule. 
Serum ECP should also be followed to determine changes in the disease activity of non-
IgE-mediated allergy and the effectiveness of an elimination diet for food additives in 
atopic dermatitis. 
The interpretation of the results of allergen-specific tests, such as the skin prick test and 
allergen-specific IgE, is often complicated because the number of positive SPT responses, the 
spectrum of IgE sensitisation and even the results for the same allergen often change in the 
same individual over time [26]. This variability may be related to the number of allergens 
tested and the age at which the measurements are performed. The most common food 
allergens determined with the SPT are soy, cow's milk, peanuts, carrot, hen's eggs whites, 
wheat, and corn [27]. 
However, changes in reactivity to allergens must be considered to be a natural phenomenon 
that is affected by the natural outgrowing of food allergy and the gradual acquisition of 
allergy to inhaled allergens, including house dust mites and pollen [2]. The change in the 
number of allergens to which a patient responds over time and the change in response to 
one allergen over time provides the physician with information on the progress of the 
disease. If the number of sensitised allergens decreases, the allergy itself may be regarded to 
be decreasing systemically. In addition, if the strength of SPT or the level of food-specific 
IgE is decreasing, the patient may be outgrowing the allergy. 
4.3 Oral food challenge 
The gold standard to confirm or disprove food allergy is the OFC, particularly double-
blinded, placebo-controlled OFCs [8]. In the case of NFA, OFCs are safe, whereas in IFA, 
OFCs are time-consuming and carry the potential for severe reactions. They should be 
performed by experienced health-care professionals who have access to emergency 
equipment. Despite the mentioned caveats, OFCs are especially useful because observation 
for 24 hours or more after food exposure allows the assessment of both early and late 
reactions to the food and thus can detect both IgE- and non-IgE-mediated processes. 
4.3.1 Prerequisites for oral food challenge in atopic dermatitis 
Evaluation of clinical severity scores 
For the diagnosis of food allergy, a clinical severity scoring system is necessary. This scoring 
differs between IFA and NFA. The diagnosis of IFA is straight forward because of the 
apparent clinical manifestation following a challenge. There are several scoring systems for 
IFA described by Clark [28] and Noh [6]. The diagnosis of NFA is difficult due to its clinical 
characteristics, which are almost the same as those of atopic dermatitis, and the SCORAD 
index and clinical severity scoring systems for AD can be used for NFA [29]. Clinical 
severity scoring should be done at the initial evaluation, at every visit, and before and after 
every procedure.  
1. Diet record 
A dietary diary should be kept during diagnosis and treatment [2]. In the process of 
management of food allergies in AD, daily diet diaries should be used to record complete 
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basic recipes for each meal. For the supervision of dietary management, all food should be 
recorded, including elimination diets, open OFCs, and tolerance induction. This is especially 
important for breast-feeding infants. In such cases, the diet of the mother should be 
recorded along with the diet of the infant, including the times of ingestion and the time of 
the appearance of new AD lesions or aggravation of old AD lesions. 
2. Elimination diet  
An elimination diet should precede an oral food challenge. Without complete elimination of 
the causes of the allergy provocation, it is difficult to interpret the results of an oral food 
challenge [2].  
For IFA, the causative foods are typically easily recognised by parents and patients; it is 
therefore easy to eliminate and challenge with foods. However, it is very difficult to 
recognise the triggers for the diagnosis to be made in NFA. The accumulated statistics for 
NFA in atopic dermatitis are absolutely necessary [2]. Moreover, in cases of NFA associated 
with atopic dermatitis, the causative agents are more complicated and may include HDM 
[30]; thus, all possible allergens must be eliminated for a proper oral food challenge. 
Fortunately, the proper control of the causative allergens, including food and inhaled 
allergens, can be evaluated based on stable improvement during an elimination diet. An 
initial elimination diet is important as an indicator of the proper control of allergy 
provocation [2]. 
Once patients show improvement through an initial elimination diet, oral food challenges 
are conducted. Foods that were not addressed in the initial elimination diet should also be 
considered. IFN- therapy can be considered when patients do not improve following the 
initial elimination diet [2] because IFN- therapy itself does not affect allergy provocation 
during the next OFC [20]. 
3. Basic general management 
Without basic care and the control of allergens other than foods, the precise diagnosis of 
food allergies may be confusing. This type of management includes the following: 1) Skin 
care using non-steroid drugs and emollients including moisturizer and aroma oil, 2) House 
dust mite and other inhaled allergen care (dander, pollen, fungi and others); patients should 
be tested for allergy provocation by inhaled or environmental allergens, 3) Other factors 
(infection control, others), 4) Discontinue all medications that affect allergy provocation 
(steroids, antihistamines, other immunosuppressants, drugs with unknown effects (herbal 
medications), etc [2]. 
4.3.2 Elimination diets as a first step in the diagnosis of food allergies 
1. Elimination diet and elementary diet 
Diet control for the elimination of food allergy can be assessed using an elimination diet and 
an elementary diet. An elimination diet is a restriction of the possibly causative foods, 
whereas an elementary diet permits several safe foods. Both approaches require clinical data 
from studies [18, 19, 21]; such data are very important because if the clinical statistics are not 
proper, dietary restriction does not result in clinical improvement. The proper OFC then 
cannot be advanced further.  
For an effective elementary diet, the absolutely safe foods in atopic dermatitis should be 
addressed. An effective elimination diet is a higher modality because it requires the 
accumulation of clinical data for statistics regarding the causative foods for atopic 
dermatitis. Noh and Lee focused on these points, and an effective elimination diet is now 
available for atopic dermatitis [12, 13, 18, 19, 21].  
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More than 50% of AD patients have NFA . Without the control of allergy provocation, AD 
cannot be effectively controlled [21]. As a first step in the diagnosis of food allergy, dietary 
restrictions should be initiated. If a patient shows improvement on an elimination diet, a 
food allergy to the restricted foods should be strongly suspected. An optimal elimination 
diet can be achieved by providing a list of the foods to be restricted, which in turn can be 
determined by clinical statistics. 
2. Breast-fed infants 
In the case of breast-fed infants, maternal elimination diets are recommended. Once a maternal 
elimination diet is implemented, improvements are often observed in the infant [31]. If eczema 
improves during the elimination diet, the clinical relevance of the eliminated foods should be 
confirmed with standardised, physician-supervised oral food challenges to the mother. 
4.3.3 Oral food challenge 
Through OFC, the suspected foods should be listed with the classification of type of allergy, 
and a relevant elimination diet that eliminates only suspected foods should result in an 
improvement of AD symptoms [2]. The order for the OFC should prioritise NFA before IFA. 
Additionally, the importance of certain foods should be considered according to the 
patient’s wishes. An OFC for NFA should generally precede an OFC for IFA. Each OFC is 
conducted according to the relevant protocols. 
1. Principle of oral food challenge in AD (Goldmann’s triad): intake, elimination diet and 
challenge test 
The diagnosis of food allergy follows the standard principle of Goldmann’s triad [19]. 
When patients show symptoms and signs after the ingestion of suspected causative foods, 
an elimination diet is initiated. If the patient shows improvement with this diet, the 
eliminated food is strongly suspected as the cause of AD. If the patient again shows the 
clinical manifestation with subsequent food challenge, the challenged food is confirmed as 
the cause of AD.  
2. Proper elimination of foods as an absolute condition for OFC 
An elimination diet is the first effective way to confirm a food allergy in AD. However, a 
proper elimination diet is necessary [2]. Unless such a diet is performed, it is likely that 
elimination will be ineffective. A proper elimination diet is essential and should not be 
omitted.  
4.3.4 Types of OFC 
There are various types of OFC that may be clinically indicated, including open, single-
blind, double-blind, and placebo-controlled trials. The choice of the type of OFC is based on 
a clinical assessment of the potential for bias in the interpretation of the results) [32]. Open 
OFC is the unmasked, unblinded administration of a food in its natural form. Open OFC is 
recommended for IFA because IFA is associated with a clear clinical manifestation. 
Moreover, in NFA, open OFC is effective in the clinical setting and can be performed on an 
out-patient basis. Open OFC is a cost-efficient procedure that saves substantial time and 
resources. It is thus considered to be a reasonable first choice for evaluating an adverse 
reaction to a food when the need for an OFC has been established.  
Blinding and masking by mixing the challenge food with a masking vehicle or placing the 
food in vehicles, including opaque capsules or powders, reduces bias [32]. In the single-
blind OFC, the observer but not the patient knows the food being tested. In the double-blind 
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OFC, the challenge material is provided by a third party, such as a dietitian, and the patient, 
the patient’s family, and the observer are unaware of when the test food is administered. 
Bias is thus minimised. Placebo-controlled challenges may be administered in either a 
single-blind or double-blind fashion. 
4.3.5 Indications for an OFC 
Indications for an OFC in AD are listed below [2, 20, 32]; 1) Identify foods causing AD for 
the initial diagnosis of a food allergy and for monitoring resolution of the food allergy, 2) 
Discriminate between IFA and NFA, 3) Calibrate the provoking dose and determine the 
clinical severity of the reaction for therapeutic purposes in IFA and in order to monitor 
progress in IFA treatment, 4) Expand the diet in persons who have multiple dietary 
restrictions because of subjective complaints, such as headaches or hyperactive behaviour, 5) 
Assess the status of tolerance to cross-reactive foods, 6) Assess the effect of food processing 
on food tolerability, e.g., fruits and vegetables that may be tolerated in cooked form in the 
pollen-food allergy syndrome. 
4.3.6 OFC procedures for IFA and NFA 
The basic concept of OFC is the same for IFA and NFA. However, due to the different 
clinical characteristics of the two types of allergy, the OFC protocols for each differ 
significantly in principle and in dosage protocol [7]. OFC is conducted with relevant 
protocols for IFA or NFA. An OFC for IFA is relatively easy and simple, with higher risk, 
whereas an OFC for NFA is intricate and all aspects of this OFC should be carefully 
considered. 
- IFN- in OFC 
IFN- does not inhibit allergy provocation [19]; however, it does improve the pre-existing 
symptoms and signs of atopic dermatitis, including eczematous skin lesions and pruritus 
[19, 21]. The clinical characteristics of AD are of the non-IgE-mediated type, and the 
onset and duration of symptoms and signs are relatively longer [7]. It is difficult to 
handle or proceed to the next challenge when the patient shows a severe NFA reaction 
during the challenge. The use of steroids or antihistamines for symptomatic treatment 
can inhibit the allergic reaction caused by OFC or hide the symptoms of allergy 
provocation during an OFC.  
4.3.7 Clinical characteristics of OFC 
1. IFA and NFA 
Rapid onset and apparent clinical manifestations are typical of IFA [7]. During proceeding 
with the OFC for food allergy, the onset time following challenge, the duration of symptoms 
and signs, and the various clinical manifestations should be considered. Although the 
diagnosis of NFA is made based on the change of clinical severity scores, expertise is 
necessary in the OFC for NFA because the same food may provoke variable clinical 
manifestations with an unexpected onset time during the challenge.  
2. Characteristics of OFC  
The characteristics of food allergy are well described by Noh and Lee [7]. The clinical 
characteristics of food allergy to the same food may differ among patients and may differ in 
the same patient according to the type of food. Some foods, such as shrimp and mackerel, 
tend to provoke IgE-mediated food allergy, whereas other foods, such as milk, eggs, 
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soybeans and wheat, tend to provoke both IgE- and non-IgE-mediated food allergies. Other 
foods, such as meats, tend to predominantly provoke non-IgE-mediated food allergy. 
According to the characteristics of the region, the kinds of foods that cause food allergy also 
differ. Patients who live near the sea tend to have allergies to seafood, whereas patients who 
live in land tend to have less frequent allergies to seafood. Allergy to rice is less frequent in 
Oriental countries than in Western countries, whereas wheat allergy is more frequent in 
Oriental countries than in Western countries. 
The statistics on food allergy are very important in clinical practice. Basically, the foods that 
should be restricted in the initial elimination diet for the control of food allergy in atopic 
dermatitis have been identified based on the statistics on food allergy [12, 13, 18, 19, 21]. The 
necessary statistics should be based on challenge tests conducted at least with open OFC and 
not on laboratory results because IgE-based tests cannot predict the presence of food allergy, 
particularly for non-IgE-mediated food allergy in atopic dermatitis. 
Interestingly, meat (beef, chicken, pork) has not been recognised as an important cause of 
food allergy in atopic dermatitis because meats induce predominantly non-IgE-mediated 
food allergies [12, 13, 18, 19, 33]. From the statistics, fewer than 5% of patients have allergies 
to chicken and pork simultaneously. Therefore, if a patient shows an allergy to either 
chicken or pork, the physician can predict the possibility that the other may not provoke 
allergy in the patient. Approximately 10% of patients have allergies to both milk and eggs; 
thus, if a patient is allergic to either milk or eggs, the possibility that the patient has allergy 
to the other is less than 10%. Similar data are available for soybeans and wheat. The use of 
statistics is thus very helpful in managing food allergies related to atopic dermatitis.  
Patients sometimes think that they may be allergic to beef if they are allergic to milk 
because milk comes from cows. However, this is not the case. Milk and beef have no 
statistical relationship as causes for food allergy in atopic dermatitis [12, 13, 18, 19, 33]. The 
same is the case for chicken and eggs. Physicians and dietitians should consider these points 
in the management of food allergy in atopic dermatitis. 
4.4 Diagnosis of food allergy in infants 
4.4.1 Breast-feeding infants and children 
If an infant develops severe eczema while it is exclusively breast-fed, it is essential to 
consider a food allergy provoked by proteins in the breast milk. All food proteins can pass 
from the maternal diet into breast milk [31]. If an allergy due to exposure to a protein via 
maternal milk is diagnosed, it is necessary to modify the diet of the mother with 
professional dietetic support and supervision. Previously, in cases where multiple foods 
were implicated or there were concerns about maternal nutrition, it was appropriate to 
suggest the substitution of an appropriate milk formula. However, with the advent of 
tolerance induction, TIFA for allergenic foods is also available.  
For the diagnosis of food allergy in the breast-feeding infant, OFC is performed through 
the mother [2]. Improvement of the baby following an elimination diet in the mother 
should occur before proceeding with an OFC. The mother ingests the challenge food and 
the baby consumes the breast milk. The baby is then evaluated following the same 
processes. The important point is that the baby should consume breast milk within a 
specified time (1-2 hours) after the mother ingests the challenge food. If the baby does not 
improve with the mother’s elimination diet, IFN- therapy can be administered to the 
baby to elicit clinical improvement. 
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Because of its nutritional purpose, this process is designed to identify completely safe foods 
rather than allergenic foods [2]. According to the OFC protocol for breast-fed babies, it is 
very important to list the foods that can be ingested by the mother that are completely safe 
for the baby. The primary purpose of the diagnosis of food allergy is to provide safe recipes 
for the infant and the mother. Subsequently, the test results will be applied to the infant 
during the phase of solid food introduction. Safe foods will be introduced with priority. An 
OFC is conducted on the mother using normal protocols; the sole difference is that the food 
is given to the mother and reactions are observed in the infant. 
4.4.2 Formula-feeding infants 
In formula-feeding babies, the OFC is simpler than in breast-feeding infants [2]. The primary 
purpose of treatment is to set up safe formula feeding with casein hydrolysate, soy formula or 
other foods. To rule out milk allergy, challenge with casein hydrolysate will be performed for 
the diagnosis of allergy, especially to casein. If the infant improves with casein hydrolysate, he 
or she is allergic to casein and casein hydrolysate formula is be used until weaning.  
If the baby does not improve on casein hydrolysate formula, it is subsequently challenged 
with amino acid-based formula. If the baby improves, the baby is allergic to components 
other than casein in milk or together with allergic to casein. The baby can then be fed the 
amino acid-based formula or be tested on soy formula. If the baby cannot tolerate the amino 
acid-based formula and has an allergy to casein hydrolysate, or if the parents wish to feed 
the baby soy formula, a soy formula challenge can be performed. If the baby improves with 
the soy formula, the baby is allergic to milk and can be fed with soy formula until weaning. 
TIFA for any formula is indicated when the baby does not improve with either soy formula 
or casein hydrolysate or when the baby does not tolerate amino acid-based formula [2]. 
Parents can select the kinds of foods (milk or soy) to be tolerised. After tolerance induction 
for formula, the baby is fed the tolerised formula until weaning. 
4.4.3 Mixed-feeding baby (breast-feeding with formula feeding) 
An initial elimination diet for the mother is conducted with simultaneous feeding of a safe 
formula, as described above [2]. After initially setting the baby up with safe formula feeding 
and diet restriction of the mother, an OFC of the mother for the diagnosis of food allergy in 
the infant should be performed as described above. 
4.4.4 Solid food introduction for baby (approximately 5-12 months) 
The primary purpose of diagnosis is to set up a safe recipe for the infant to prevent 
nutritional deficiencies due to elimination diets or food allergies [2]. Transiently, an 
elimination diet should be conducted in the mother and all solid foods should be stopped in 
the infant (elimination diet of infant and mother). Due to nutritional considerations, 
elimination for the infant and the mother should not be conducted for more than 3 days. If 
the baby does not improve, IFN- therapy for the baby is indicated during subsequent OFCs 
of the baby. If the baby improves following an elimination diet of the mother and baby with 
or without IFN-, sequential introduction of solid foods may be performed according to the 
weaning schedule. However, the sequence of foods can be changed according to the 
circumstances of the infant and the mother. The mother and infant should be 
simultaneously fed with the same challenge foods. In case of formula feeding infants, stop 
all solid foods to the infant (elimination diet in the infant) and simultaneously set up a safe 
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formula feeding during the elimination diet in the infant, as described above. Sequential 
introduction of solid foods should be performed according to the weaning schedule. 
Nutritional care for the infant is essential. 
5. Immunotherapy for food allergy in AD 
Presently, there are 3 therapeutic approaches for food allergies. In all cases, the allergen 
should be avoided until proper treatment is administered [9]. In infants and young children, 
the allergenic food(s) should be excluded from the diet until the allergy is outgrown unless 
exclusion results in nutritional deficiency or the allergen cannot be avoided; in such cases, 
active treatment, such as tolerance induction for food allergy (TIFA), is performed [2]. If 
exclusion cannot be practiced, patients may experience discomfort caused by non-IgE-
mediated food allergy and atopic dermatitis or reactions as serious as anaphylaxis from 
repetitive ingestion of the allergenic food(s). However, with the recent advent of TIFA 
treatment, management of atopic dermatitis has improved remarkably [7]. 
Clinical tolerance can develop over time; this process is also called “outgrowing” the 
allergy. Allergies to milk and eggs are common food allergies that are outgrown: 80% of 
children with milk and egg allergies show tolerance by the age of 3 to 5 years [8]. In contrast, 
only about 20% of young children develop tolerance to peanuts, and less than 10% outgrow 
an allergy to tree nuts. However, the persistence of food allergy is variable and depends on 
the specific food allergen. 
5.1 Specific Immunotherapy for food allergy 
Allergen-specific therapies have been investigated to achieve desensitization and/or tolerance 
to an allergen [34]. Desensitization is defined as a change in the threshold dose of ingested 
food allergen necessary to cause allergic symptoms. Tolerance is the induction of long-term 
immunologic changes associated with the ability to ingest a food without showing symptoms 
and without ongoing therapy. In a recent pilot study [35], subcutaneous immunotherapy 
(SCIT) was well tolerated in children with milk allergy. Despite its efficacy in treating food 
allergy as well as allergic rhinoconjunctivitis and venom hypersensitivity, this traditional 
approach to allergen immunotherapy is impractical and unsafe for the treatment of food 
allergies because of an unacceptably high rate of anaphylactic reactions in IgE-mediated food 
allergy [34]. Sublingual immunotherapy (SLIT) has a broad efficacy for the treatment of 
inhalant allergies. SLIT has been used to treat hazelnut allergy and a life-threatening kiwi 
allergy. Currently, trials are in progress to evaluate the efficacy of SLIT in treating other food 
allergies. Traditional Chinese Medicine represents an innovative approach with the potential 
to treat food allergies although this approach is not allergen-specific. Food Allergy Herbal 
Formula (FAHF-2) is reported to promote tolerance and protection from anaphylaxis in mouse 
models. Further, human clinical trials are just beginning and hold promise for future clinical 
efficacy. Omalizumab is a recombinant, humanized, monoclonal anti-IgE antibody that was 
demonstrated to significantly increase the threshold peanut protein dose necessary for allergic 
response in oral food challenge, thereby providing potential protection from accidental peanut 
ingestion. Clinical trials are in progress to evaluate both anti-IgE monotherapy for food allergy 
and the use of omalizumab as an adjunct to oral immunotherapy. While this therapy is 
suitable for IgE-mediated food allergy, it is not applicable for treatment of non-IgE-mediated 
food allergy. Protection from peanut allergic response has also been demonstrated in a report 
where rectal immunization with mutated peanut protein allergens protected mice from 
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anaphylaxis, Peptide immunotherapy has also been investigated using the immunodominant 
epitopes of ovalbumin.  
5.2 Oral immunotherapy for food allergy: Tolerance induction for food allergies (TIFA) 
or specific oral tolerance induction (SOTI)  
Oral immunotherapy appears to be effective in inducing desensitization in most patients, as 
well as oral tolerance in a subset of patients with food allergy [34]. Oral immunotherapy was 
officially introduced in 1996 in "Monographs in Allergy" [36, 37]. Noh & Lee reported the 
first successful use of oral immunotherapy for food allergy [38]. They used IFN- as the 
adjuvant for oral immunotherapy for food allergy and named this therapy “specific oral 
tolerance induction (SOTI)” in 2003. SOTI was attempted for IgE-mediated food allergy in 
humans by several investigators [5, 34, 39-43]. The complete SOTI protocol for IgE-mediated 
food allergy was accomplished by also using IFN- in 2009 by Noh & Lee [6]. 
Several terms are used to describe oral immunotherapy for food allergy. These terms are 
based on an escalating dosage of orally ingested foods or food protein to induce immune 
tolerance for allergenic food(s). Tolerance induction for food allergy (TIFA) was first coined 
by Noh & Lee in 2003 [38]. Specific oral tolerance induction (SOTI) is currently the more 
precise term to describe oral tolerance induction for specific allergens in food allergy, and 
this term, SOTI, was also used first by Noh in 2003 in a report on milk-specific oral tolerance 
induction for non-IgE-mediated food allergy in atopic dermatitis. Tolerance induction for 
food allergy (TIFA) is a similar term that has a broader immunologic meaning: to induce 
immune tolerance for allergenic foods by any method. 
5.3 IFN- in food allergy and AD 
IFN- was introduced for the correction of Th1/Th2 imbalance, which is the basic 
immunologic mechanism in allergies, including food allergy [21]. As expected, 
desensitization for house dust mites was successful when IFN- was used, but was 
ineffective without IFN- [30]. Moreover, IFN- seemed to show tolerogenic effects in 
addition to its corrective effects in Th1/Th2 imbalance [7]. Especially, IFN- was absolutely 
necessary for TIFA for non-IgE-mediated food allergy. Other than SOTI, effective treatment 
methods for non-IgE-mediated food allergy by using IFN- have not been established. 
Without IFN-, tolerance is not induced in non-IgE-mediated food allergy. 
5.4 Indication for SOTI 
Tolerance induction for food allergy is indicated when (1) nutritional deficiency is expected, 
(2) the patient is inevitably unable to avoid the allergen (e.g., wheat allergy in a baker), (3) 
an infant displays allergy to all available formulae, and (4) the patients or parents want an 
improved quality of life [2]. 
6. Prevention of food allergy 
6.1 Breastfeeding for the prevention of food allergy 
Breast milk is the gold standard for protective nutrients fed to newborn infants, and present 
clinical evidence supports the strong protective effect of breast milk against age-related 
infectious gastroenteritis [44]. An important function of early breastfeeding is its anti-
inflammatory effect on the immature, excessive inflammatory response in newborns. 
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Several components of breast milk, including transforming growth factor (TGF)-beta, 
interleukin (IL)-10, erythropoietin, and lactoferrin, can reduce the inflammatory response to 
stimuli in the newborn intestine. Although, historically, there has been widespread support 
for the concept that breast-feeding is protective against atopic disease in general, 
breastfeeding could facilitate food allergies in certain cases by allowing transfer of the 
allergens from the mother’s diet through breast milk. Exclusive breastfeeding for 4 months 
should be recommended to prevent atopic disease; however, there is no evidence to support 
the protective effect of exclusive breastfeeding beyond this period. Mixed feeding should be 
encouraged until 6 months of age.  
6.2 Delayed introduction to solid foods to prevent the development of food allergy 
An additional question regarding food allergy and AD is whether delaying the 
introduction of solid foods to infants at a high risk for AD can delay or prevent the 
development of AD. The most recent clinical report states that exclusive breast feeding for 
4 to 6 months for infants who are at a high risk for AD (i.e., positive family history) can 
help prevent or delay AD; furthermore, cow’s milk should not be introduced until 2 years 
of age in order to prevent allergy [11]. No convincing evidence exists to delay the 
introduction of any solid food beyond 4 to 6 months of age. In contrast, dairy products are 
recommended to be introduced at 12 months; hen’s egg at 24 months; and peanuts, tree 
nuts, fish, and seafood at 36 months.  
Attempts to avert the development of food allergy through primary prevention strategies 
such as early restriction of dietary allergens and modified timing of complementary solid 
food introduction to infants have proven to be frustrating and possibly counter-productive. 
Early dietary restriction of peanuts is recommended to avoid sensitization [34]. However, 
early consumption of food proteins and subsequent oral tolerance induction in infants and 
children may be a key element in preventing the development of food allergies. In another 
study, neither the diversity nor the timing of introduction of complementary foods had any 
association with development of eczema. The most recent recommendations for high-risk 
infants do not endorse restriction of maternal diet during pregnancy and lactation or 
restriction of allergenic foods in infants after 4–6 months of age.  
Elimination of highly allergic foods is plausible to prevent the development of food allergy 
[34]. Concerning the timing of solid food introduction, a delay does not seem to prevent the 
development of food allergy, but it may enhance sensitization to some foods. Introducing 
solid food at 4–6 months might result in the lowest allergy risk and the recommended 
duration of exclusive breast feeding and age of introduction of solids were confirmed to be 6 
months [46]. Exclusive breastfeeding for at least 4 months for infants at a high risk of 
developing atopic disease but no current convincing evidence that delaying solid food 
introduction, including fish, eggs, and foods containing peanut protein, beyond 4–6 months 
of age had a significant protective effect on the development of atopic disease [47]. In 
contrast, early introduction of peanuts during infancy, rather than avoidance, was reported 
to prevent the development of peanut allergy [48]. Their data might be a good example of 
oral immune tolerance in a human model. 
In contrast, some reports have suggested that delaying the introduction of hyperallergenic 
solid foods during weaning is not effective in preventing the development of food allergy. A 
new concept about the timing of weaning and the introduction of solid foods was suggested 
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[49]. Avoidance of highly allergenic foods beyond 4–6 months might not be effective in 
preventing the development of food allergy in most children, and the effect of specific early 
introduction of allergenic foods was being investigated. Significantly, delaying the 
introduction of solid foods until 4 to 6 months of age in infants at a high risk for atopic 
disease appears to reduce the incidence of AD [11]. 
6.3 Elimination of hyperallergenic foods from the diet of prenatal or breastfeeding 
mothers  
Opinions about a mother’s diet during breast feeding differ. Whether a mother should 
follow an elimination diet for hyperallergenic foods to prevent food allergy remains a 
matter of debate [2]. From prenatal development studies, however, there is no evidence to 
support the assumption that an elimination diet can prevent food allergy because the 
mother’s immune system protects the fetus from foods ingested by the mother. 
6.4 Correction of Th1/Th2 imbalance 
The development of food allergy is related to Th2-deviant immune status in the sensitization 
phase of AD [9]. Although IFN- has tolerogenic effects on pre-existing food allergy, the 
development or prevention of a food allergy is primarily associated with sensitization. IFN- 
plays a role in preventing food allergy by correcting the Th1/Th2 imbalance [21]. 
6.5 Prevention of allergy provocation 
The diagnosis of food allergy and subsequent elimination diet of all possible allergenic foods is 
important to prevent further sensitization from repetitive allergy provocation. Repetitive 
allergy provocation and the resultant further Th2-polarization make patients more likely to 
develop additional allergies [2]. Sensitization to more food allergens, as well as aeroallergens, 
can occur with repeated allergy flares. It follows that allergy provocation by known allergens 
should be avoided to prevent further sensitization. For this reason, AD should be evaluated for 
repetitive allergy provocation and not simply the severity of AD. Furthermore, patients with 
mild AD should be treated early to prevent repeated allergic responses. 
6.6 IL-10 for the prevention of food sensitization 
Helminths induce generation of IL-10 in the gut and prevent sensitization to foods in mice 
[50]. Promotion of an IL-10-rich environment in the gut was investigated for its role in 
preventing or even treating food allergies. The prevention of food allergies by administering 
either an IL-10-secreting Lactococcus lactis [51] or an avirulant Salmonella typhimurium strain 
that promotes IL-10 secretion in the gut [52] was demonstrated. In this study, transiently 
expanded IL-10-secreting T cell populations played an important role in keeping the 
allergen-specific effector T cell responses in check. From these results, it was possible to 
explain how skin exposure to high doses of allergens led to a decreased immune response 
with subsequent allergen exposures [53]. 
6.7 Skin hydration 
Physical injury leads to a Th2-deviant status in the local skin and resultant allergic status 
(Fig. 2) [54]. These changes result in sensitization to simultaneously exposed allergens as 
described above. Dryness is one of the main causes of itching. For all aspects of AD symptoms, 
skin hydration is very important to prevent further sensitization through the skin. 
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Fig. 2. Immunopathogenesis of sensitization through skin. Physical injury induced the 
release of thymus stromal lymphopoietin (TSLP) in the skin and subsequently IL-21 is 
released from Th2 cell by TSLP. By the multiple actions of IL-21, the skin is Th2-polarized. In 
this process, also many Th2-related cytokines are involved including IL-4, IL-5, IL-13, IL-16, 
IL-31, IL-32. Any allergens exposed simultaneously in this status, are sensitized in skin. If 
skin is sensitized by IgE-mediated allergy, skin prick test to sensitized allergens becomes 
positive, while if skin is sensitized by non-IgE-mediated allergy, allergy patch test may 
become positive with the development of atopic dermatitis. 
6.8 Restriction of food additives 
Food additives play a role in food allergy and AD by acting as pseudoallergens [25]. 
Ingestion of food additives leads to dryness and itching [24]. Physical injury by scratching 
due to dryness and itching results in sensitization to additional allergens [54]. This cycle of 
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dryness and injury caused by scratching contributes to repeated allergic responses (Fig. 2). 
In order to prevent sensitization to multiple allergens, use of food additives should be 
restricted. 
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